Navigation Links
Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
Date:1/25/2013

DEERFIELD, Ill. and OSAKA, Japan, Jan. 25, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

"Takeda is pleased with the FDA approval of NESINA, OSENI and KAZANO for the treatment of type 2 diabetes, a therapeutic category in which we have more than twenty years of clinical and patient experience," said Douglas Cole , president, Takeda Pharmaceuticals U.S.A., Inc. "Millions of people are affected by diabetes and, as a leader in the diabetes arena, Takeda is dedicated to working to advance patient care and helping to meet the needs of this growing patient population."

NESINA is a dipeptidyl peptidase-4 inhibitor (DPP-4i) that is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). OSENI, which combines alogliptin with pioglitazone, is the first product in the U.S. to include both a DPP-4i and a thiazolidinedione (TZD) in a single tablet. KAZANO combines alogliptin with metformin HCl, a widely used anti-diabetes medication, in a single tablet.

The most common adverse events (greater than or equal to 4%) reported with NESINA include nasopharyngitis, headache and upper respiratory tract infection. With regard to OSENI, common adverse events (greater than or equal to 4%) reported include nasopharyngitis, back pain and upper respiratory tract infection. Common adverse events (greater than or equal to 4%) re
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
2. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
3. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
4. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
5. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
6. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
7. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
8. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
9. American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment
10. PrimeMail, Prime Therapeutics mail-service pharmacy, receives URAC Reaccreditation
11. Brolex C SAFE cesarean section safety device receives top scores, rated a MUST HAVE medical device for performing c/sections.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Mark Riccio, director of Cornell ... is using the online crowd-funding platform Kickstarter to ... to researchers and would-be superheros everywhere: "for FREE." ... YOU do if you had Superman,s X-ray vision?" ... explorers everywhere, from elementary through high school students, ...
(Date:8/22/2014)... 22, 2014  Cannabis Science, Inc. (OTC: CBIS), ... development and related consulting, is pleased to announce ... cannabis conference taking place at the Faculty of ... on October 22, 2014.  The multilingual conference brings ... researchers, health professionals, and patients, to discuss the ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... March 16, 2011 Reportlinker.com announces that a ... catalogue: Global Freeze Drying Equipment ... This report analyzes the worldwide markets for ... following Product Segments: Laboratory Freeze Drying Equipment, and ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Analgesics ... This report analyzes the worldwide markets ... segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others ...
Cached Medicine Technology:Global Freeze Drying Equipment Industry 2Global Freeze Drying Equipment Industry 3Global Freeze Drying Equipment Industry 4Global Freeze Drying Equipment Industry 5Global Freeze Drying Equipment Industry 6Global Freeze Drying Equipment Industry 7Global Freeze Drying Equipment Industry 8Global Freeze Drying Equipment Industry 9Global Freeze Drying Equipment Industry 10Global Freeze Drying Equipment Industry 11Global Freeze Drying Equipment Industry 12Global Freeze Drying Equipment Industry 13Global Freeze Drying Equipment Industry 14Global Freeze Drying Equipment Industry 15Global Analgesics Industry 2Global Analgesics Industry 3Global Analgesics Industry 4Global Analgesics Industry 5Global Analgesics Industry 6Global Analgesics Industry 7Global Analgesics Industry 8Global Analgesics Industry 9Global Analgesics Industry 10Global Analgesics Industry 11Global Analgesics Industry 12Global Analgesics Industry 13Global Analgesics Industry 14Global Analgesics Industry 15Global Analgesics Industry 16Global Analgesics Industry 17Global Analgesics Industry 18Global Analgesics Industry 19Global Analgesics Industry 20Global Analgesics Industry 21Global Analgesics Industry 22
(Date:8/22/2014)... DENVER For the first time an oncogenic somatic ... during transfection) protein has been identified in small cell ... mutation within SCLC cell lines produced increased intracellular signaling ... form of lung cancer representing 15% of all lung ... representing 85% of lung cancer, has been extensively examined ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Mueller Sports ... Plantar Fasciitis, an exciting new product that provides non-drug ... to stay active while you heal. The package includes ... truly a new technology – it is not kinesiology ... FasciaDerm® PFTape™ System for Plantar Fasciitis is ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader ... participating in Merrill Lynch,s 19th Annual Global,Pharmaceutical, Biotechnology ... 5, 2008, at 8:00 a.m. Eastern Time., ... accessed via Zimmer,s,Investor Relations website at http://investor.zimmer.com ...
... several years of research into the gecko,s uncanny ability to ... have developed an adhesive that is the first to master ... feet. The material could prove useful for a range of ... tape or glue, the new material is crafted from millions ...
... giving radiation, study says , , TUESDAY, Jan. 29 ... gender and medical training, may influence whether a ... a U.S. study suggests. , Many breast ... conservation therapy, even though it,s been shown to ...
... disease , , TUESDAY, Jan. 29 (HealthDay News) -- A man,s ... of sex hormones circulating in his bloodstream, a new British ... of 18 studies -- representing 95 percent of all available ... and blood hormone levels, the study authors said. , "There ...
... Jan. 29 The following statement,was issued today by ... expected spin-off of Philip Morris International as a separate,company, ... greater,variety of deadly and addictive products around the world, ... implement proven measures to,reduce tobacco use and save lives. ...
... Jan. 29 Answering President,Bush,s State of the ... solutions to reform the nation,s retirement programs, the ... Center for Assisted,Living (AHCA/NCAL) and Alliance for Quality ... on this front by taking up long term,and ...
Cached Medicine News:Health News:The pitter patter of little feet... climbing straight up a wall 2Health News:Surgeons' Characteristics Influence Breast Cancer Care 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 3Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 2Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 3Health News:Answering Bush SOTU Retirement Reform Challenge, Long Term Care Profession Urges Congress to Enact Bold Reform of Long Term and Post Acute Care Delivery Systems 2
3.2 mm Keratome, double bevel, sharp sides, ang. 1 Ea as quantity....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
Microcontroller-based isolated electrosurgical generator, designed for all general purpose surgical procedures. Unit includes: Instant Response technology, adaptive REM system, isolated output, CEM c...
Lorgnette pinhole occluder...
Medicine Products: